Pharmaceutical Intermediates Antidepressant Raw Powders Mirtazapine CAS 85650-52-8

Model NO.: 85650-52-8
Name: Mirtazapine
CAS: 85650-52-8
Grade: Pharmaceutical Grade
Color: White Crystalline Powder.
MF: C17H19N3
MW: 265.35
Trademark: HongQiang
Transport Package: Foil Bag or Tin
Specification: 1kg/tin bag, 25kg/drum
Origin: China
HS Code: 2942000000
Model NO.: 85650-52-8
Name: Mirtazapine
CAS: 85650-52-8
Grade: Pharmaceutical Grade
Color: White Crystalline Powder.
MF: C17H19N3
MW: 265.35
Trademark: HongQiang
Transport Package: Foil Bag or Tin
Specification: 1kg/tin bag, 25kg/drum
Origin: China
HS Code: 2942000000
Mirtazapine


Quick Detail: 
Product Name: Mirtazapine
CAS NO.: 85650-52-8
Molecular Formula: C17H19N3
Molecular Weight: 265.35
Purity: 99%
Appearance: White Powder
Grade: Pharmaceutical Grade



Description:
Mirtazapine, is an atypical antidepressant with noradrenergic and specific serotonergic activity. It blocks the α2 adrenergic auto- and heteroreceptors (enhancing norepinephrine release), and selectively antagonizes the 5-HT2 serotonin receptors in the central and peripheral nervous system. It also enhances serotonin neurotransmission at the 5-HT1 receptor and blocks the histaminergic (H1) and muscarinic receptors. Mirtazapine is not a serotonin or norepinephrine reuptake inhibitor but may increase serotonin and norepinephrine by other mechanisms of action.

Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA),and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic and appetite stimulant. In structure, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA) and is the 6-aza analogue of mianserin.It is also racemic - occurs as a combination of both (R)-(−)- and (S)-(+)-stereoisomers, both of which are active.

 

Dosage:
Oral, can swallow with water, do not chew. The initial dose of adult treatment is 15mg (1/2 tablet) once daily, and then gradually increase the dose for optimal efficacy. The effective oral dose is usually 15-45mg (1/2 tablet-1.5 tablet) per day. Patients with liver and kidney damage, mirtazapine clearance decreased, so these patients medication should be noted. The half-life of mirtazapine is 20-40 hours, so medication can be done once a day, before going to bed to take effect better. Can also be sub-service, sooner or later each time. Patients should continue to take medicine, preferably in the symptoms disappear completely 4-6 months after withdrawal. Appropriate doses within 2-4 weeks will have a significant effect. If the effect is not obvious, the dose can be increased until the maximum dose, such as 2-4 weeks after the dose was still no significant effect, should immediately stop the medication .


COA:
Items Standard    Result
    Appearance White or off-white powder Complies 

Identification

The IR absorption spectrum is accordant with the spectrum obtained with CRS

Complies 
 Solubility ,
Practically insoluble in water,freely soluble in anhydrous ethanol

Complies 

specific rotation
-0.10°~+0.10°
(anhydrous substance)
+0.001°
Water ≤3.5% 2.8%
Sulfated ash ≤0.10% 0.04%
granularity  80%<75 m 39.28 m
Residual solvents Ethanol ≤5000ppm 130ppm

Impurity
Impurity A A≤0.10% ND
  Impurity B B≤0.10% ND
  Impurity C C≤0.10% ND
  Impurity D D≤0.10% ND
  Impurity E E≤0.10% ND
  Impurity F F≤0.10% ND
  Individual impurity ≤0.10% ND
  Total impurities ≤0.20% ND

Microbial limit test
aerobic bacteria≤1000CFU/g <10CFU/g
  fungus≤1000CFU/g <10CFU/g
  Absence of escherichia coli ND
 Assay 99.0~101.0%(anhydrous substance) 100.0%
Conclusion Complies to EP7.0



Antidepressant Related material 

Paroxetine 
Sertraline
Fluvoxamine maleate,
Citalopram hydrobromide,
Duloxetine hydrochloride,
Venlafaxine hydrochloride     
Duloxetine
Bupropion
Trazodone
Nefazodone
Mirtazapine
Moclobemide
Escitalopram
Gabapentin hydrochloride
Mirtazapine


Quick Detail: 
Product Name: Mirtazapine
CAS NO.: 85650-52-8
Molecular Formula: C17H19N3
Molecular Weight: 265.35
Purity: 99%
Appearance: White Powder
Grade: Pharmaceutical Grade



Description:
Mirtazapine, is an atypical antidepressant with noradrenergic and specific serotonergic activity. It blocks the α2 adrenergic auto- and heteroreceptors (enhancing norepinephrine release), and selectively antagonizes the 5-HT2 serotonin receptors in the central and peripheral nervous system. It also enhances serotonin neurotransmission at the 5-HT1 receptor and blocks the histaminergic (H1) and muscarinic receptors. Mirtazapine is not a serotonin or norepinephrine reuptake inhibitor but may increase serotonin and norepinephrine by other mechanisms of action.

Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA),and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic and appetite stimulant. In structure, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA) and is the 6-aza analogue of mianserin.It is also racemic - occurs as a combination of both (R)-(−)- and (S)-(+)-stereoisomers, both of which are active.

 

Dosage:
Oral, can swallow with water, do not chew. The initial dose of adult treatment is 15mg (1/2 tablet) once daily, and then gradually increase the dose for optimal efficacy. The effective oral dose is usually 15-45mg (1/2 tablet-1.5 tablet) per day. Patients with liver and kidney damage, mirtazapine clearance decreased, so these patients medication should be noted. The half-life of mirtazapine is 20-40 hours, so medication can be done once a day, before going to bed to take effect better. Can also be sub-service, sooner or later each time. Patients should continue to take medicine, preferably in the symptoms disappear completely 4-6 months after withdrawal. Appropriate doses within 2-4 weeks will have a significant effect. If the effect is not obvious, the dose can be increased until the maximum dose, such as 2-4 weeks after the dose was still no significant effect, should immediately stop the medication .


COA:
Items Standard    Result
    Appearance White or off-white powder Complies 

Identification

The IR absorption spectrum is accordant with the spectrum obtained with CRS

Complies 
 Solubility ,
Practically insoluble in water,freely soluble in anhydrous ethanol

Complies 

specific rotation
-0.10°~+0.10°
(anhydrous substance)
+0.001°
Water ≤3.5% 2.8%
Sulfated ash ≤0.10% 0.04%
granularity  80%<75 m 39.28 m
Residual solvents Ethanol ≤5000ppm 130ppm

Impurity
Impurity A A≤0.10% ND
  Impurity B B≤0.10% ND
  Impurity C C≤0.10% ND
  Impurity D D≤0.10% ND
  Impurity E E≤0.10% ND
  Impurity F F≤0.10% ND
  Individual impurity ≤0.10% ND
  Total impurities ≤0.20% ND

Microbial limit test
aerobic bacteria≤1000CFU/g <10CFU/g
  fungus≤1000CFU/g <10CFU/g
  Absence of escherichia coli ND
 Assay 99.0~101.0%(anhydrous substance) 100.0%
Conclusion Complies to EP7.0



Antidepressant Related material 

Paroxetine 
Sertraline
Fluvoxamine maleate,
Citalopram hydrobromide,
Duloxetine hydrochloride,
Venlafaxine hydrochloride     
Duloxetine
Bupropion
Trazodone
Nefazodone
Mirtazapine
Moclobemide
Escitalopram
Gabapentin hydrochloride

Disinfection And Sterilization Equipment

Plasma Air Sterilizer,Plasma Air Sterilizing Machine ,Air Sterilization Purifier,Bio Plasma Air Sterilizers

Foshan Ja Suo Medical Device Co., LTD , https://www.jasuodental.com